Reddit Posts
Top 8 Breakout Candidates for the week of 8/30
Mentions
CRBU announces they used their new chRDNA platform to create two gene therapies with 0 off target edits 0 graft v host and 90% response rate. Stock launches 200% premarket and bleeds out all the gains???
Wish some stocks here had more short stock availability. Mspr just then was the most obvious short at $0.8 sideways trading after a huge pump. Phio was another likely short at $4.4 sideways trading at resistance in premarket. Arec too, same story as Mspr, with sideways trading around $5.5 after a huge pump. Msai was less obvious, although none of the stocks I just mentioned had shorts available anyway so whatever. For the ones that did actually have SSA, glad to have shorted CRBU for a nice profit near its premarket high today, and scalped a small short win on Dvlt and Femy on open.
Buy CRBU the next INTS
Given the surge premarket, I think entry into CRBU at this price isn't too bad. Also watching IOVA for an entry because their data seemed pretty promising.
https://www.stocktitan.net/news/CRBU/caribou-biosciences-announces-positive-data-from-ca-m-mouflage-phase-la0ji00s4wh2.html Summary of the recent announcement
I'm in and to be fair. This was absolute luck. I created a bio basket bet just past week and CRBU was one of ten stocks
What is CRBU doing. Pre-market is up 180%. I wonder if they really found something or if they plan to rug pull me by noon just for fun.
That's not entirely true, since often enough stocks like that incl. the DD behind why there is an upside are shared on Reddit. Two examples I personally caught are GME back in the day and BYND just last week. In both cases, the posts on Reddit were enough to get me to do my own research and then enter with a small position based on my usual risk management. In case of CRBU you can also find a couple of posts across several different sub-reddits within the last couple of weeks.
If you are late to CRBU, pls consider ACRV!
Thanks brotha. Next is CRBU $2 calls for 1/16/26. Expecting 100%+ again here
Yesszir. It usually never hits that amount of time and I’ll always sell before then. Next is CRBU $2 calls 1/16/26 expiry
I'm liking what CRBU is doing for me today.
Crispr-cas9 is the hot thing in biotech right now. It’s used for gene editing and in the future gene editing will be able to solve basically any disease ever. CRBU is co-founded by the woman who co-invented the tech and also co-founded NTLA. She is working with CRBU to develope a crispr hybrid RNA-DNA (chRDNA). This chRDNA will make the existing crispr tech work better be more accurate and have less unintended gene edits which have unintended consequences. ChRDNA will make crispr safer and more effective, it is also a platform that can be patented and then CRBU can license it to all the other biotech crispr companies and make billions. Trial data for their two proof of concept therapies CB-010 and CB-011 will be released by end of year. Stock has moved from 0.66 to 2.60 in anticipation but mcap is still around 300m which means this has upside potential to easily 10-20x if the results are good. I’m betting on the competence of Jennifer Dounda who invented crispr, won a Nobel prize, and cofounded NTLA. Bad results kills the thesis but she has proven to be a good bet and the upside far outward the downside here.
If CRBU trials come out good what’s a realistic market cap? Crspr is 6.5 billion and CRBUs chRDNA is basically just an improvement to crispr cas9 tech.
“what’s the next biotech to triple like NTLA” maybe the other company founded by the NTLA founder? CRBU leaps cause crispr is the future
Now I’m telling you CRBU $2 calls for 1/16/26 expiry
PFE most likely will buyout CRBU as well stepping into CRISPR space
CRBU and NTLA. What are your thoughts? Of course I'm a bag holder
EDIT, CRBU, CBUS. I do really like ABAT, though I sold because so many battery players in the game right now. HIT is a great long-term stock methinks. I think TLRY has a chance a recapturing significant value after earnings and if/once Trump DEA announces rescheduling of THC to Schedule III.
Long-term: CRBU, CBUS, EDIT, PACB. As usual. Short-term: IXHL (as everyone knows), and also TLRY. Earnings next week for TLRY and if Trump Admin announces rescheduling of marijuana to Schedule III, look out.
You think that's fun. Look at CRBU. And imagine you bought near the bottom
Same as always: CRBU, EDIT, CBUS. long term gene editing stocks. I think WSB is pumping DNUT now. They move quickly lol
Thank you, love the animal stocks. Seem to surge (Gorilla GRRR, Caribou CRBU, Wolf WOLF,) There's 2 dragonfly's (Dragonfly Draganfly)
I've been bagholding since '21. I drank the CRSPR koolaid back then and also bought EDIT and CRBU. I even got the Jennifer Doudna "Crack in Creation" audiobook and listened to that. Any thoughts on Caribou (CRBU)? CRSP and EDIT and a few others are the traditional plays. I've felt ok holding those and think they'll make ATH again someday. Not sure about CRBU though. That's a stock I feel I got suckered into.
Okay, I bit man. 641 shares @0.78. I’m hoping at least one of my Alzheimer’s/Dementia/biotech plays will workout very long term. Currently in $ALZN, $CLLS, $CRBU, $PACB, $SGMO, $TNXP, $UNCY, $VXRT. Now adding $CGTX to that list. All went in for around $500. Some are up, some are down. Likely holding until moon or zero.
You all can keep chasing your white whales. I'll just keep DCA'ing on EDIT, CRBU, and CBUS every time one of them dumps in the morning hours.
I will continue to shill for long-term plays: CRISPR/gene editing stocks EDIT, CRBU, and CBUS. Also will continue to support anyone that wants to jump into ASBP as an end-of-August play. Looking to get back into IXHL if it starts to slide back to a realist price, as we haven't seen data yet. Really just want to go take gains once again before the stock craps out for a while while it can't actually produce the drugs it's studying OPEN looks like it may have but those who didn't get out, but it could pump. I think the next big stock with a possible squeeze is UGRO
Now is the time to get into gene editing. Plenty of companies under 5$ (EDIT, CRBU, CBUS, PACB) that have moonshot potential the MOMENT one of their gene therapies works out. CBUS is already rolling out altered agriculture products and getting paid royalties - a big hitter once people realize how fucked we are when it comes to soil/water/heat conditions next twenty years.
This is one of the few penny stocks (along with CRISPR stocks CRBU, CBUS, EDIT) that I like long-term. Technology that will be EXTREMELY potent in the future.
All of them follow the same trend - EDIT, CRBU, NTLA, PACB The "smaller" CRISPR stocks hit higher percentage gains but take bigger beatings, too. The ones I'd be interested in optioning would be EDIT and CRBU. But I'd rather buy the shares outright TBH
CRBU, IXHL, OPEN I only have a position in CRBU fwiw
If you are looking for a serious answer, my money would be on one of the CRISPr gene-editing companies. EDIT, CRBU, BEAM, NTLX, CRSP. Some have already begun utilizing their sequencing to save lives. Others are beginning to patent additional sequencing. I think the BIG one will come when a company realizes how to edit agricultural genetic code to utilize less nutrients, and grow in harsher climates.
I believe CRBU has a great potential with its allogeneic CAR-T therapies for hematological cancers and autoimmune diseases and its current valuation which is lower than peers.
CRBU has gone from $1.85/share in the past couple of months to nearly $3 now. A good option to take a look at.
CRISPR Therapeutics and Vertex Pharma. I have about three percent of my total portfolio in gene editing stocks (CRSP/VRTX/NTLA/CRBU). Very risky investments IMO, but I'm planning to hold them all for decades. In the case of CRSP/VRTX, my time horizon is forever.
is this stock better than CRBU? maybe i should cut down research time on CRBU and focus on this IMTX
Guys lets push $CRBU to the moon, do it for me
Guys can we get $CRBU up, I’m broke
$CRBU is going to go up pretty fast
I have a boat load of CRSP/CRBU shares in my IRA but other than that no
Crispr stocks: NTLA, EDIT, CRSP, BEAM, CRBU (maybe wait for a bit more drop on this one), also RIVN
https://preview.redd.it/3nfk4ntdthpc1.jpeg?width=1284&format=pjpg&auto=webp&s=3844304a00c093b6dbb962846e428c4cb86acfbd $CRBU insiders are loading up great chance to buy cheap
$CRBU, do it now before its too late. Long term option call hold in expire in October just watch
No I’m holding all major players but at different position sizes based on my confidence in the company, CRSP is my largest position by far but that’s also because it’s grown a lot recently, followed by NTLA, BEAM, VERV, CRBU, PRME, EDIT, GRPH
CRBU, they have a crucial clinical trial result coming out in March.
10$ Long call on $CRBU expiring in Oct. the stock is up 36% since Jan. Option up 17% today. 👌👌👌🔥
10$ Long call on $CRBU expiring in Oct. the stock is up 36% since Jan. Option up 17% today. Trust this one boys👍
Biotech are like lottery tickets, find one with something that hasn’t been approved yet and buy it low, and wait. You either win the morning they get fda approval for whatever drug, or they dilute/RS you into oblivion. I’m holding DARE, ARDX, and XLO, and watching CRBU, CARM, and PLX.
Acknowledged! Thanks for the write-up. I have a large bagholder position in CRSP too. I drank the Crispr tech kool aid and am also bagholding EDIT and CRBU. I'm not in MRNA anymore but it's always on my watchlist. I bought it in the mid 20s at the start of the pandemic and sold when it doubled, which was very painful as I watched it 10x after I sold. If it falls back near to my sell price I might get back in.
If these biotech companies come out with good clinical results or interest comes back to biotechs, these biotechs are an easy 2 to 3x. I am personally bullish on CRBU, Dr Jeniffer Doudna (inventor of Crispr) is cofounder and they have made many complete remissions from cancer in Phase1 trial which is why Pfizer ended up buying 25m$ equity in it.
Buy more CRBU. Always.
Here is CRBU’s latest presentation. https://investor.cariboubio.com/static-files/3168b9f6-48dd-4e44-8103-df5ff9013b6b
ALLO is a good bet and so is Caribou Biosciences (CRBU). They had many remissions in Phase 1 Trials and looks promising for Car-T cell therapy.
You could find a discounted stock like CRBU who just has Pfizer make a significant investment in their cancer/lymphoma genetic based research. I picked up a few units today for my portfolio.
I'm invested in CRBU, that's why I asked.
What do you think about their investment into Caribou Biosciences (CRBU)?
The only good thing about PFE is that they just invested in gene editor CRBU.
$CRBU bag holders Lmao 
$CRBU Crash will be awesome to see
$CRBU will crash and leave Bag holders with losses
$CRBU Crash incoming Lmao
💰💰💰Get new runners in our app! #premarket #watchlist 07/6 $MULN - Announces $25 Million Stock Buyback Program (+66%), $AKU - no news + big volume (+30%) $CRBU - Announces $25 Million Equity Investment from Pfizer (+21%), $KZIA - awarded Fast Track Designation (FTD) by the United States Food and Drug Administration (FDA) (+18%) https://preview.redd.it/x8hbkiuubcab1.jpeg?width=576&format=pjpg&auto=webp&v=enabled&s=5e8cb6dcec140e8d7a6c2981d695b7cc16a5ab06
💰💰💰Get new runners! #premarket #watchlist 07/6 $MULN - Announces $25 Million Stock Buyback Program (+66%), $AKU - no news + big volume (+30%) $CRBU - Announces $25 Million Equity Investment from Pfizer (+21%), $KZIA - awarded Fast Track Designation (FTD) by the United States Food and Drug Administration (FDA) (+18%) https://preview.redd.it/dbkb6qksbcab1.jpeg?width=576&format=pjpg&auto=webp&v=enabled&s=0b4c0de621a1c4ac5f30168f782051ff28652279
30k as an emergency fund. The rest I would take a chance and split between two genomics stocks. Probably CRBU and CRSP. If that works out I would sell at some point and dump it all into VOO or SPY on pullbacks and sell calls
I have 1/3rd of my portfolio allocated for micro and small caps that have the potential to 10x or more. These are the high risk, not yet profitable companies with huge upside potential. So far most of mine are green energy and biotech related \-SAVA (Alzheimer's stage 3 drug) \-CRBU ( crisper genome cell therapies ) \-EOSE (zinc battery grid storage, lithium alternative) \-EXROF (EV efficient car parts) \-EEMMF (lithium) Enphase was previously on this list when I started buying at $15 and it became my first 1,000% gain. Looking for more ideas... What are your top 2 picks and why?
I have an undergraduate degree in microbiology, but I’m absolutely incapable of explaining it. I just think gene editing will be part of the future of medicine and I think one of the few big CRISPR companies will either make money or get bought. I own EDIT and CRBU.
LABU in general. CRBU is my most regarded play.
They are crushing it and are relatively safe. Small caps have so much more risk and less reputable boards have a lot of spam pumpers. With that said, I do think the market “bottomed” from highs last November. Interest hikes are prices in. There are a lot of exciting under 1 b companies that ipo’d high, have cool tech, and a long runway. I like cell and gene therapy companies like CRBU and SANA. There is lose everything or 10x in a decade potential there
I chose GNOM over ARKG when I decided I didn't have time to track my CRISPR stocks (CRSP, NTLA, BEAM, CRBU) individually. It has a lower cost basis than ARKG, a larger percent of it's top 10 holdings directly in gene-editing companies (14.66% to 12.42%), and I just don't trust Cathie Wood. For example, she has Teledoc as the 4th largest holding in ARKG, which is allegedly a "Genomic Revolution" ETF. How does Teledoc fit? I **love** UiPath, but why is an RPA SaaS company almost 2% of a genomics ETF? Why is there $300,000 in ONEM, a primary care company? Bizarre.
Anyone here have CRBU? Looks good but can't understand the low volume rn
SANA and CRBU... small cap bio-techs took too much of a beating after getting healthy IPOs, and are now set with strong balance sheets to rock
GNOM because time matters now that I have a baby and following the companies in my CRISPR basket (CRSP, NTLA, BEAM, and CRBU) wasn't worth the time anymore but I still wanted skin in the gene-editing game.
Caribou biosciences (CRBU). They’re the Tesla of allogeneic therapy.
I own BEAM, CRBU, CRSP and NTLA. EDIT is also another popular one. They'll be profitable if/when they have a drug/treatment come to market. However, that is a long ways away. The total cost basis for my basket of 4 stocks equals the cost basis of one of my normal individual stocks. Very high reward with a very high risk. If you want a better grasp on the biotechnology and the possibilities, read The Code Breaker. One of my favorite books that I read last year. Entertaining and not overly complicated when explaining CRISPR and gene-editing.
Preach. I hold CRSP, CRBU, BEAM, and NTLA in my IRA.
As of 3/31/22: * NTLA is 38% * BEAM is 27% * CRSP is 26% * CRBU is 10% They all started with the same total $ cost basis though. CRBU has... not been well received by investors lol
Same. I think biotech at large has trended down as people sought to get into energy and commodity focused stocks and away from growth plays. Probably a good time to plus up my CRBU allocation using some of my gains from those sectors.
* NNOX. If they and their x-ray tech doesn't turn out to be a complete and utter fraud, they will revolutionize x-rays. Could easily see them being a $62B MC. * LLNW if management ever gets their shit together. * BGRY if they can execute. * Any of the CRISPR companies (CRBU, CRSP, EDIT, NTLA, BEAM, etc.)
Hope you're right about the CRSPR tech. My bags are heavy with CRSP, EDIT, and CRBU.
Caribou Biosciences, CRBU, a front runner in Gene editing crispr technology
Don't go! I'm holding CRBU and want to hear (read) more!
…and when she’s at her most desperate, I’ll tip her about my deep value propositions in RKLY, CRBU, & ASTR
Ur picks are in that vast gap between big tech and no rev tech, which is an area we like to avoid at the moment. They’ve all hit massive valuations and are bearing the brunt of the sell off (and could continue to do so). Prefer barbelling between the big tech and no rev super growth moonshots. Lots of these firms raised cash last year and have incredibly cheap enterprise values from the sell-off. For the moonshots, own shares or calls in RKLY, CRBU, IONQ, ASTR, & PACB. RKLY has the best near term price catalysts due to a med device product launch this year, potentially with Medtronic (a VC stage investor). And the possibility of being the key feature upgrade in this or next year’s Apple Watch (Apple was disclosed as a client during the listing).
Crisper stocks....NTLA, BEAM, EDIT, CRBU Fintech .... wPLCF, paypal, sq